Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Lassiter

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Neuroscience Letters|March 30, 2001
Complement inhibition does not reduce post-hypoxic-ischemic cerebral injury in 21-day-old ratsH A Lassiter, R C Feldhoff, N Dabhia, et al.
Pediatric Research|April 1, 1994
Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coliH A Lassiter, J L Wilson, R C Feldhoff, et al.
The American Journal of Pediatric Hematology/Oncology|February 1, 1993
Neonatal immune neutropenia following the administration of intravenous immune globulinH A Lassiter, K W Bibb, S J Bertolone, et al.
The Journal of Pediatrics|April 1, 1991
Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsisR D Christensen, M S Brown, D C Hall, et al.
The American Journal of the Medical Sciences|September 26, 2001
Nonspecific human IgG reduces survival in neonatal rats infected with Escherichia coliC W Cole, R C Feldhoff, L J Goldsmith, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 1, 1990
Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulinH A Lassiter, M J Speranza, R T Hall, et al.
The American Journal of the Medical Sciences|May 20, 1998
Complement component C9 enhances the capacity of beta-lactam antibiotics to kill Escherichia coli in vitro and in vivoE Jung, R C Feldhoff, B M Walz, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 1, 1996
Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1H A Lassiter, T W Robinson, M S Brown, et al.
Pediatric Research|July 1, 1997
The administration of complement component C9 enhances the survival of neonatal rats with Escherichia coli sepsisH A Lassiter, B M Walz, J L Wilson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neuroscience Letters|March 30, 2001
Complement inhibition does not reduce post-hypoxic-ischemic cerebral injury in 21-day-old ratsH A Lassiter, R C Feldhoff, N Dabhia, et al.
Pediatric Research|April 1, 1994
Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coliH A Lassiter, J L Wilson, R C Feldhoff, et al.
The American Journal of Pediatric Hematology/Oncology|February 1, 1993
Neonatal immune neutropenia following the administration of intravenous immune globulinH A Lassiter, K W Bibb, S J Bertolone, et al.
The Journal of Pediatrics|April 1, 1991
Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsisR D Christensen, M S Brown, D C Hall, et al.
The American Journal of the Medical Sciences|September 26, 2001
Nonspecific human IgG reduces survival in neonatal rats infected with Escherichia coliC W Cole, R C Feldhoff, L J Goldsmith, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 1, 1990
Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulinH A Lassiter, M J Speranza, R T Hall, et al.
The American Journal of the Medical Sciences|May 20, 1998
Complement component C9 enhances the capacity of beta-lactam antibiotics to kill Escherichia coli in vitro and in vivoE Jung, R C Feldhoff, B M Walz, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 1, 1996
Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1H A Lassiter, T W Robinson, M S Brown, et al.
Pediatric Research|July 1, 1997
The administration of complement component C9 enhances the survival of neonatal rats with Escherichia coli sepsisH A Lassiter, B M Walz, J L Wilson, et al.
Pageof 2